Erik P Pioro

Cited by

	All	Since 2019
Citations	10846	4273
h-index	49	32
i10-index	106	68

960

480

240

720

1990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202434 53 61 78 67 57 46 79 110 128 133 135 110 117 161 137 212 229 259 311 309 362 368 388 478 494 471 468 520 596 664 831 954 902 313

Public access

View all

62 articles

6 articles

available

not available

Based on funding mandates

Co-authors

claudio cuelloProfessor and Charles E Frosst/Merck Chair in PharmacologyVerified email at mcgill.ca
Nimish ThakoreCleveland ClinicVerified email at ccf.org
Jeffrey CummingsCleveland Clinic Lou Ruvo Center for Brain HealthVerified email at ccf.org
Ranjan DuttaAssociate Professor, Molecular MedicineVerified email at ccf.org
Richard M. RansohoffThird Rock VenturesVerified email at thirdrockventures.com
Dan LittmanSkirball Institute, NYU School of MedicineVerified email at med.nyu.edu
Douglas Lorne Arnold, MD, FRCP(C)James McGill Professor: Department of Neurology and Neurosurgery, Faculty of Medicine, McGillVerified email at mcgill.ca
John RavitsUniversity of California, San DiegoVerified email at ucsd.edu
Alfredo Ribeiro-da-SilvaProfessor of Pharmacology & Therapeutics, McGill UniversityVerified email at mcgill.ca
Anne Kloos, PT, PhD, NCSProfessor-Clinical, The Ohio State UniversityVerified email at osu.edu
Vanina Dal Bello-HaasSchool of Rehabilitation Science, McMaster UniversityVerified email at mcmaster.ca
David B. Arciniegas, MDUniversity of Colorado School of MedicineVerified email at ucdenver.edu
Nicola De StefanoProfessor of Neurology, Universtiy of Siena,Verified email at unisi.it
Paul M. MatthewsEdmond and Lily Safra Chair, Professor of Clinical Neurosciences, Imperial College LondonVerified email at imperial.ac.uk
Sridar Narayanan, PhDAssistant Professor: Department of Neurology and Neurosurgery, McGill UniversityVerified email at mcgill.ca
Neil CashmanUniversity of British ColumbiaVerified email at vch.ca
Loutfi S. AboussouanCleveland ClinicVerified email at ccf.org
David Alan SchoenfeldProfessor of MedicineVerified email at partners.org
Francois BethouxCleveland ClinicVerified email at ccf.org
Martin R. TurnerNuffield Department of Clinical Neurosciences, Oxford UniversityVerified email at ndcn.ox.ac.uk

Erik P Pioro

Lewis John Pollack Professor of Neurology, Ken & Ruth Davee Dept of Neurology, Northwestern

Verified email at northwestern.edu

ALS MND MRI neuroimaging PBA


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Control of microglial neurotoxicity by the fractalkine receptor AE Cardona, EP Pioro, ME Sasse, V Kostenko, SM Cardona, IM Dijkstra, ... Nature neuroscience 9 (7), 917-924, 2006	1713	2006
Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1268-1283. e6, 2018	576	2018
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis JO Johnson, EP Pioro, A Boehringer, R Chia, H Feit, AE Renton, ... Nature neuroscience 17 (5), 664-666, 2014	514	2014
Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes PM Andersen, KB Sims, WW Xin, R Kiely, G O'Neill, J Ravits, E Pioro, ... Amyotrophic lateral sclerosis and other motor neuron disorders 4 (2), 62-73, 2003	372	2003
Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system—II … EP Pioro, AC Cuello Neuroscience 34 (1), 89–110, 1990	349	1990
Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system—I … EP Pioro, AC Cuello Neuroscience 34 (1), 57-87, 1990	349	1990
Amyotrophic lateral sclerosis H Mitsumoto Current Science and Approaches to Therapy, 2005	339	2005
A clinical trial of creatine in ALS JM Shefner, ME Cudkowicz, D Schoenfeld, T Conrad, J Taft, M Chilton, ... Neurology 63 (9), 1656-1661, 2004	336	2004
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial EJ Sorenson, AJ Windbank, JN Mandrekar, WR Bamlet, SH Appel, ... Neurology 71 (22), 1770-1775, 2008	278	2008
Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions S Narayanan, L Fu, E Pioro, N De Stefano, DL Collins, GS Francis, ... Annals of neurology 41 (3), 385-391, 1997	271	1997
A randomized controlled trial of resistance exercise in individuals with ALS VD Bello-Haas, JM Florence, AD Kloos, J Scheirbecker, G Lopate, ... Neurology 68 (23), 2003-2007, 2007	261	2007
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III P Kaufmann, JLP Thompson, G Levy, R Buchsbaum, J Shefner, ... Annals of Neurology: Official Journal of the American Neurological …, 2009	258	2009
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis ME Cudkowicz, JM Shefner, DA Schoenfeld, RH Brown Jr, H Johnson, ... Neurology 61 (4), 456-464, 2003	252	2003
Dextromethorphan plus ultra Low‐Dose quinidine reduces pseudobulbar affect EP Pioro, BR Brooks, J Cummings, R Schiffer, RA Thisted, D Wynn, ... Annals of neurology 68 (5), 693-702, 2010	218	2010
Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo EP Pioro, JP Antel, NR Cashman, DL Arnold Neurology 44 (10), 1933-1933, 1994	214	1994
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy PM Matthews, E Pioro, S Narayanan, ND Stefano, L Fu, G Francis, J Antel, ... Brain 119 (3), 715-722, 1996	207	1996
Defining and diagnosing involuntary emotional expression disorder JL Cummings, DB Arciniegas, BR Brooks, RM Herndon, EC Lauterbach, ... CNS spectrums 11 (S6), 1-11, 2006	195	2006
1H-MRS evidence of neurodegeneration and excess glutamate glutamine in ALS medulla EP Pioro, AW Majors, H Mitsumoto, DR Nelson, TC Ng Neurology 53 (1), 71-71, 1999	163	1999
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis S Bandres‐Ciga, AJ Noyce, G Hemani, A Nicolas, A Calvo, G Mora, ... Annals of neurology 85 (4), 470-481, 2019	160	2019
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS M Benatar, L Zhang, L Wang, V Granit, J Statland, R Barohn, A Swenson, ... Neurology 95 (1), e59-e69, 2020	150	2020

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors